688166 博瑞医药
2025/06 - 中期
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
经营活动产生之现金流量净额113,613245,559194,765311,259176,075
投资活动产生之现金流量净额(387,303)(440,142)(439,854)(871,576)(889,838)
筹资活动产生之现金流量净额244,111(24,475)61,6111,364,686703,722
汇率变动对现金及现金等价物的影响6,3102,1182,78314,1513,722
现金及现金等价物净增加/(减少)(23,269)(216,939)(180,694)818,520(6,319)
期初现金及现金等价物余额754,102971,0411,151,735333,215339,534
期末现金及现金等价物余额730,833754,102971,0411,151,735333,215